Condition
Pneumonia, Ventilator-Associated clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Pneumonia, Ventilator-Associated clinical trials that are recruiting, at sites in 6 countries (most in France (5), Spain (1), Norway (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 6Countries
Newest Pneumonia, Ventilator-Associated clinical trials
All recruiting trials (8)
-
Reducing ventilator-associated pneumonia in newborns in the NICU
This project will see if training NICU teams and using standardized care protocols can lower ventilator-associated pneumonia in babies on mechanical ventilation.
-
Ventilator-associated pneumonia rates and use of SRLF 2017 diagnostic rules in an ICU (2022–2024)
This project will look at respiratory samples from adults on mechanical ventilation in a regional ICU to see if doctors followed the SRLF 2017 rules when diagnosing ventilator-associated pneumonia between 2022 and 2024.
-
Antibiotic approaches for Stenotrophomonas maltophilia pneumonia in ICU patients
This study tests whether using one antibiotic versus two, and whether treating for 7 days versus 14 days, helps adults on ventilators in the ICU with Stenotrophomonas maltophilia pneumonia survive and avoid recurrence.
-
Examining immunity markers in ICU patients with ventilator-associated pneumonia
This study is trying to see if measuring certain immune markers in ICU patients with ventilator-associated pneumonia can help improve their treatment and outcomes.
-
Using sequencing to predict outcomes of pneumonia in ventilated patients
This study is testing if analyzing germs in the lungs of patients on ventilators can help predict how well they will recover from pneumonia.
-
Using interferon gamma to treat pneumonia in ICU patients on ventilators
This study is testing if a treatment called interferon gamma can help improve recovery for adults on ventilators who have pneumonia while in the ICU.
-
Strategy using bacterial DNA detection to guide antibiotics in immunocompromised patients with ventilator-associated or hospital-acquired pneumonia
This study tests whether using a PCR-based method to tailor antibiotics in immunocompromised ICU patients with suspected VAP or HAP on mechanical ventilation can improve the use of targeted antibiotics within 24 hours of diagnosis.
-
Evaluating biomarkers for pneumonia in ventilated patients
This study is testing if certain biological markers in the body can help doctors better diagnose and predict pneumonia in patients on ventilators in the ICU.
Related topics
Quick answers
How many Pneumonia, Ventilator-Associated clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in France (5 trials), Spain (1 trial), Norway (1 trial), Portugal (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.